WORK PACKAGE 10
Country Vignettes
As part of WP10 – Appraisal of orphan medicinal products, HTA appraisal/reimbursement processes for rare disease treatments in most EU and EEA Member States, Canada and New Zealand have been documented.
These country vignettes are now publicly available and can be found in the list below. More information on how this was done can also be found in the background document below.
​
​
​
​
Click on a flag to download the country vignette [PDF]
Australia
Austria
Belgium
Bulgaria
Canada
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Malta
Netherlands
New Zealand
Norway
Poland
Portugal
Romania
Russia
Slovakia
Slovenia
Spain
Sweden
Switzerland
UK/England
UK/Scotland
United States
Leads
Università Commerciale Luigi Bocconi
University of Edinburgh
​
Principal Investigators
​
​